Patents Issued in October 21, 2008
-
Patent number: 7439238Abstract: This invention relates to the use of certain C-10 substituted derivatives of artemisinin of general formula (I) in the treatment and/or prophylaxis of diseases caused by infection with a parasite, certain novel C-10 substitued derivatives of artemisinin, processes for their preparation and pharmaceutical compositions containing such C-10 substituted derivatives. The compounds are particularly effective in the treatment of malaria, neosporosis and coccidiosis.Type: GrantFiled: January 9, 2006Date of Patent: October 21, 2008Assignee: The Hong Kong University of Science and TechnologyInventors: Richard K. Haynes, William Wai-Lun Lam, Ho-Wai Chan, Hing-Wo Tsang, Man-Ki Cheung, Gisela Greif, Gabriele Schmuck, Arnd Voerste
-
Patent number: 7439239Abstract: Disclosed are compounds, compositions and methods for treating various diseases and conditions, including pain. Such compounds are represented by Formula I as follows: wherein A, G, Y, R3-R5 are defined herein.Type: GrantFiled: December 21, 2005Date of Patent: October 21, 2008Assignee: Janssen Pharmaceutica N.V.Inventors: Steve Coats, Scott L. Dax, Bart DeCorte, Li Liu, Mark McDonnell, James J. McNally
-
Patent number: 7439240Abstract: The present invention therefore provides a compound of formula (I) and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.Type: GrantFiled: June 23, 2003Date of Patent: October 21, 2008Assignee: AstraZeneca ABInventors: Andrew Bailey, Garry Pairaudeau, Anil Patel, Stephen Thom
-
Patent number: 7439241Abstract: In methods, compounds, and topical formulations for treatment of rosacea incorporating compounds represented by the formulas below: wherein each of R1, R2, and R3 is independently hydrogen, hologen, alkyl, or alkoxy; each of R4 and R5 is independently hydrogen, alkyl, or alkoxy; and each of R6 and R7 is independently hydrogen, nitro, alkyl, or alkoxy; wherein each of A1, A3, and A4 is independently hydrogen or alkyl; and A2 is independently hydrogen or hydroxy; and wherein each of B1, B2, and B3 is independently hydrogen, hydroxy, or alkoxy; and each of B4 and B5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat rosacea and its symptoms.Type: GrantFiled: May 25, 2004Date of Patent: October 21, 2008Assignee: Galderma Laboratories, Inc.Inventors: Jack A. DeJovin, Isabelle Jean DeJovin
-
Patent number: 7439242Abstract: Modulators of PPAR? activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.Type: GrantFiled: April 15, 2002Date of Patent: October 21, 2008Assignee: Amgen Inc.Inventors: Jonathan B. Houze, Lawrence R. McGee, Steven Marc Rubenstein
-
Patent number: 7439243Abstract: Disclosed are quinoline compounds of formula (I) having pharmacological activity, processes for their preparation, compositions containing them, and methods for the treatment of CNS and other disorders.Type: GrantFiled: September 23, 2004Date of Patent: October 21, 2008Assignee: Glaxo Group LimitedInventors: Christopher Norbert Johnson, Stephen Frederick Moss, David R Witty
-
Patent number: 7439244Abstract: Disclosed are quinoline compounds of formula (I) having pharmacological activity, processes for their preparation, compositions containing them, and methods for the treatment of CNS and other disorders.Type: GrantFiled: September 9, 2004Date of Patent: October 21, 2008Assignee: Glaxo Group LimitedInventors: Christopher Norbert Johnson, David R Witty
-
Patent number: 7439245Abstract: Disclosed is a method for use of phenyl sulfone compounds of formula (I) in the treatment of anxiety.Type: GrantFiled: May 13, 2008Date of Patent: October 21, 2008Assignee: Glaxo Group LimitedInventors: Gregor James MacDonald, Mervyn Thompson
-
Patent number: 7439246Abstract: In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.Type: GrantFiled: December 1, 2005Date of Patent: October 21, 2008Assignee: Bristol-Myers Squibb CompanyInventors: Robert M. Borzilleri, Zhong Chen, Tram N. Huynh, Wayne Vaccaro, Xiao-Tao Chen, Kyoung S. Kim, Zhen-wei Cai
-
Patent number: 7439247Abstract: The present invention discloses compounds corresponding to formula wherein A, R, X, Y, R, R1 and R2 are as defined above, pharmaceutical formulations, methods of making and uses thereof.Type: GrantFiled: November 30, 2005Date of Patent: October 21, 2008Assignee: Roche Palo Altop LLCInventors: Jian Jeffrey Chen, Nolan James Dewdney, Christoph Martin Stahl
-
Patent number: 7439248Abstract: The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3-Methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenyl-methyl]thiadiazolidine-2,4-dione as active ingredient.Type: GrantFiled: November 30, 1999Date of Patent: October 21, 2008Assignees: Dr. Reddy's Laboratories Limited, Dr. Reddy's Laboratories, Inc.Inventors: Helle Weibel, Thyge Borup Hjorth
-
Patent number: 7439249Abstract: The present invention relates to compounds that inhibit phosphatases, compositions thereof, and methods of using those compounds and compositions for treating diseases.Type: GrantFiled: December 31, 2003Date of Patent: October 21, 2008Assignee: Vertex Pharmaceuticals IncorporatedInventors: Jeffrey O. Saunders, Gregory F. Miknis, Alexandre J. Buckmelter, Kevin W. Hunt, James F. Blake, Guy P. A. Vigers, Xicheng Sun
-
Patent number: 7439250Abstract: The present invention concerns the use of methods and/or compositions related to the synthesis and use of fatty asparagine, cysteine and/or serine derivatives. In particular, the invention concerns methods and compositions for the production of liposomes including fatty asparagine, cysteine and/or serine derivatives.Type: GrantFiled: November 17, 2003Date of Patent: October 21, 2008Assignee: Board of Regents, The University of Texas SystemInventors: Frederick J. Lakner, George R. Negrete
-
Patent number: 7439251Abstract: There are provided methods for the treatment of diseases involving dysfunction of the peripheral and central nervous system comprising administering one or more spiro compounds. Also provided are pharmaceutical compositions useful in such methods, compounds for use in the preparation of such pharmaceutical compositions, processes for preparing compounds useful in the practice of such methods, and some novel such compounds per se.Type: GrantFiled: May 1, 2003Date of Patent: October 21, 2008Assignee: Israel Institute for Biological ResearchInventors: Abraham Fisher, Nira Bar-Ner, Yishai Karton
-
Patent number: 7439252Abstract: The present invention provides novel crystalline forms of ascomycin as well as processes for the preparation thereof and pharmaceutical compositions comprising such crystalline forms of ascomycin.Type: GrantFiled: December 1, 2005Date of Patent: October 21, 2008Assignee: TEVA Gyógyszergyár Zártkörúen Müködö RészvénytársaságInventors: Vilmos Keri, Judith Aronhime, Erzsebet Meszaros Sos, Adrienne Kovacsne-Mezei
-
Patent number: 7439253Abstract: The invention relates to novel heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a method for preparing these compounds, and to their use as medicaments, in particular as antibacterials and ?-lactamase inhibitors.Type: GrantFiled: December 4, 2003Date of Patent: October 21, 2008Assignee: NovexelInventors: Maxime Lampilas, Branislav Musicki, Michel Klich, David Alan Rowlands
-
Patent number: 7439254Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.Type: GrantFiled: December 7, 2004Date of Patent: October 21, 2008Assignee: Cytokinetics, Inc.Inventor: Gustave Bergnes
-
Patent number: 7439255Abstract: Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.Type: GrantFiled: November 4, 2004Date of Patent: October 21, 2008Assignee: Glaxo Group LimitedInventors: Zehong Wan, Hongxing Yan, Michael R. Palovich, Dramane I. Laine
-
Patent number: 7439256Abstract: Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein A, Q, Y, R5 and J are defined herein, are useful in the treatment of cancer.Type: GrantFiled: September 15, 2005Date of Patent: October 21, 2008Inventors: Arlindo Castelhano, Andrew Crew, Hanqing Dong, An-Hu Li, Li Qiu, Alun Smith
-
Patent number: 7439257Abstract: The invention relates to a compound of formula (I): Wherein m, n, X, Y, R1, R2, R3 and R4 are as defined herein. The invention also relates to the use of same in therapeutics.Type: GrantFiled: July 11, 2006Date of Patent: October 21, 2008Assignee: Sanofi-AventisInventors: Ahmed Abouabdellah, Antonio Almario Garcia, Jacques Froissant, Christian Hoornaert
-
Patent number: 7439258Abstract: A compound of the formula I: wherein: X is CH or N; Y is O or S; Z is OH, NH2, NMeR3, NHR3; OR3 or 5- or 6-membered heterocycle, having 1 to 4 heteroatoms selected from O, N and S, said heterocycle being optionally substituted with from 1 to 4 substituents; A is N, COR7 or CR5, wherein R5 is H, halogen, or (C1-6) alkyl and R7 is H or (C1-6 alkyl), with the proviso that X and A are not both N; R6 is H, halogen, (C1-6 alkyl) or OR7, wherein R7 is H or (C1-6 alkyl); R1 is selected from the group consisting of 5- or 6-membered heterocycle having 1 to 4 heteroatoms selected from O, N, and S, phenyl, phenyl(C1-3)alkyl, (C2-6)alkenyl, phenyl(C2-6)alkenyl, (C3-6)cycloalkyl, (C1-6)alkyl, CF3, 9- or 10-membered heterobicycle having 1 to 4 heteroatoms selected from O, N and S, wherein said heterocycle, phenyl, phenyl(C2-6)alkenyl and phenyl(C1-3)alkyl), alkenyl, cycloalkyl, (C1-6)alkyl, and heterobicycle are all optionally substituted with from 1 to 4 substituents; R2 is selected from (C1-6)alkyl, (C3-7)cycloalkyl,Type: GrantFiled: May 21, 2004Date of Patent: October 21, 2008Assignee: Boehringer Ingelheim (Canada) LtdInventors: Pierre Louis Beaulieu, Gulrez Fazal, James Gillard, George Kukolj, Volkhard Austel
-
Patent number: 7439259Abstract: The present invention provides combinations of compounds of formula (I) and other therapeutic agents for the treatment of PPAR related diseases.Type: GrantFiled: August 17, 2006Date of Patent: October 21, 2008Assignee: SmithKline Beecham CorporationInventors: Rodolfo Cadilla, Romain Luc Marie Gosmini, Millard Hurst Lambert, III, Michael Lawrence Sierra
-
Patent number: 7439260Abstract: The instant invention provides compounds of Formula (I) which are leukotriene biosynthesis inhibitors. Compounds of formula (I) are useful as anti-asthmatic, anti-allergic, anti-inflammatory, cytoprotective and anti-artherosclerotic agents.Type: GrantFiled: June 8, 2004Date of Patent: October 21, 2008Assignee: Merck Forsst Canada & Co.Inventors: Yves Gareau, Helene Juteau, D. Bruce MacKay, Richard Friesen, Erich L. Grimm, Marc Blouin, Sebastien Laliberte
-
Patent number: 7439261Abstract: A novel process for the preparation of valsartan and novel intermediates useful in the preparation thereof.Type: GrantFiled: November 19, 2004Date of Patent: October 21, 2008Assignee: Dipharma S.p.A.Inventors: Giancarlo Verardo, Paola Geatti, Graziano Castaldi, Nicoletta Toniutti, Pietro Allegrini
-
Patent number: 7439262Abstract: Substituted 1-alkylamino-1H-indazoles for lowering intraocular pressure and treating glaucoma are disclosed.Type: GrantFiled: December 5, 2007Date of Patent: October 21, 2008Assignee: Alcon, Inc.Inventors: Anura P. Dantanarayana, Jesse A. May
-
Patent number: 7439263Abstract: Compounds of formula (I): wherein: X1 represents an atom or group selected from CR4aR4b, O, S(O)q1 and NR5, wherein R4a, R4b, q1 and R5 are as defined in the description, m1 represents zero or an integer from 1 to 4 inclusive, m2 represents an integer from 1 to 4 inclusive, n1 and n2, which may be identical or different, each represent an integer from 1 to 3 inclusive, R1 represents hydrogen or a group selected from carboxy, alkoxycarbonyl, optionally substituted carbamoyl and optionally substituted alkyl, R2 represents hydrogen or alkyl, Ak represents an optionally substituted alkylene chain, p represents zero, 1 or 2, R3 represents hydrogen or cyano, X2 and X3, which may be identical or different, each represent either S(O)q2, or CR6aR6b, wherein q2, R6a and R6b are as defined in the description, its optical isomers, where they exist, and its addition salts with a pharmaceutically acceptable acid. Medicinal products containing the same which are useful as DPP-IV inhibitors.Type: GrantFiled: May 18, 2005Date of Patent: October 21, 2008Assignee: Les Laboratoires ServierInventors: Guillaume De Nanteuil, Alain Benoist, Murielle Combettes, Elizabeth Harley
-
Patent number: 7439264Abstract: This invention to antagonists that inhibit transporters and receptors. The invention also relates to partial inhibitors of transporters and receptors that allow partial transport or partial binding of a compound to the transporter or receptor. The invention also relates to compounds that differentially prevent transport or binding through a transporter or to a receptor. The invention also relates to the use of these compounds for treating certain diseases and disorders.Type: GrantFiled: February 10, 2003Date of Patent: October 21, 2008Assignees: President and Fellows of Harvard College, Organix, Inc.Inventors: Peter C. Meltzer, Bertha K. Madras, Paul Blundell, Shanghao Liu
-
Patent number: 7439265Abstract: The Indo-Pacific marine sponge Ircinia ramosa has been found to contain two powerful (GI50 0.001 to <0.0001 ?g/ml) murine and human cancer cell growth inhibitors, denominated herein as irciniastatin A and irciniastatin B. Both were isolated (10-3 to 10-4% yields) by cancer cell line bioassay-guided techniques and named irciniastatins A (1) and B (2). Structural elucidation by a combination of spectral analyses, primarily high resolution mass and 2D-NMR (principally APT, HMQC, HMBC and ROESY) revealed unusual structures 1 and 2.Type: GrantFiled: November 17, 2004Date of Patent: October 21, 2008Assignee: Arizona Board of Regents, a body corporate of the State of Arizona, acting for and on behalf of Arizona State UniversityInventors: George R. Pettit, Jun-Ping Xu
-
Patent number: 7439266Abstract: The present invention relates to a novel malononitrile compound represented by the formula (A): wherein, R1 represents C1 to C6 alkyl that may be substituted with halogen, C2 to C6 alkenyl that may be substituted with halogen, etc; R2 represents hydrogen atom or C1 to C6 alkyl that may be substituted with halogen; R3 represents hydrogen atom or C1 to C6 alkyl; R4 represents hydrogen atom or C1 to C6 alkyl; R5 represents C1 to C6 alkyl that may be substituted with halogen, C3 to C6 alkenyl that may be substituted with halogen, etc, or R4 and R5 may be combined at their terminal and represent ethylene that may be substituted with C1 to C3 alkyl or trimethylene that may be substituted with C1 to C3 alkyl; and Z1 and Z2, which are the same or different, represent oxygen atom or sulfur atom. The malononitrile compound has an efficient pesticidal activity and can control effectively pests such as insect pests, acarine pests, nematode pests and the like.Type: GrantFiled: August 26, 2003Date of Patent: October 21, 2008Assignee: Sumitomo Chemical Company, LimitedInventors: Satoshi Okada, Daisuke Oohira, Ken Otaka
-
Patent number: 7439267Abstract: The present invention concerns a method of therapeutic prevention and treatment of a heart disease chosen from cardiac insufficiency and heart failure including the administration of an essential fatty acid containing a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA), either alone or in combination with another therapeutic agent.Type: GrantFiled: January 17, 2006Date of Patent: October 21, 2008Assignee: Pfizer Italia S.R.L.Inventors: Francesco Granata, Franco Pamparana, Eduardo Stragliotto
-
Patent number: 7439268Abstract: The present invention provides compositions and methods for administering florfenicol to mammals. The compositions contain a prodrug of florfenicol in a pharmaceutically acceptable carrier. In one embodiment the prodrug is an esterized form of florfenicol. Examples of suitable prodrugs include one or a combination of one or a combination of the following: florfenicol acetate, florfenicol propionate, florfenicol butyrate, florfenicol pentanoate, florfenicol hexanoate, florfenicol heptanoate, florfenicol octanoate, florfenicol nanoate, florfenicol decanoate, florfenicol undecanoate, florfenicol dodecanoate, and florfenicol phthalate. In another embodiment the prodrug is converted into the florfenicol in vivo by the action of one or more endogenous esterases. The invention also provides new compounds, pharmaceutical compositions containing the compounds, and methods for their administration.Type: GrantFiled: July 18, 2003Date of Patent: October 21, 2008Assignee: Idexx LaboratoriesInventors: Yerramilli V. S. N. Murthy, Robert H. Suva
-
Patent number: 7439269Abstract: An improved composition and method for moisturizing a nasal membrane are disclosed. The composition includes a viscous carrier and one or more moisturizing agents disposed with the carrier. The composition is applied to a portion of a nasal membrane using a spray, a swab applicator, or a similar application device.Type: GrantFiled: April 18, 2005Date of Patent: October 21, 2008Assignee: Matrixx Initiatives, Inc.Inventors: Tim Clarot, Charles Hensley
-
Patent number: 7439270Abstract: Spinal anesthetics for intrathecal administration to produce spinal anesthesia are provided with use of 6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid or its pharmaceutically active analogues.Type: GrantFiled: June 7, 2006Date of Patent: October 21, 2008Assignee: Univeristy of Iowa Research FoundationInventor: Timothy J. Brennan
-
Patent number: 7439271Abstract: Mammalian hair growth is reduced by applying an inhibitor of telomerase to the skin.Type: GrantFiled: June 27, 2001Date of Patent: October 21, 2008Assignee: The Gillette CompanyInventors: Peter Styczynski, Gurpreet S. Ahluwalia
-
Patent number: 7439272Abstract: Ultraporous sol gel monoliths and methods for preparing the same are provided, having superior flow characteristics for chromatography and analytical chemistry applications. The methods for forming an ultra porous sol-gel monolith include (a) forming a solution comprising a porogen, a matrix dissolving catalyst and a sol gel precursor; (b) allowing the solution to form a gel; and (c) drying the gel at an elevated temperature. The ultraporous sol gel monoliths are characterized by a porosity of up to about 97%, a BET surface area of at least about 50 m2/g and substantially no micropores.Type: GrantFiled: December 20, 2004Date of Patent: October 21, 2008Assignee: Varian, Inc.Inventor: Dengfeng Xu
-
Patent number: 7439273Abstract: A hydrogen generation system is disclosed that includes a fuel reforming reactor generating a hydrogen-rich reformate gas at a temperature greater than 150 C, a pressure swing adsorption (PSA) hydrogen purification unit that separates the reformate gas into a relatively pure hydrogen stream and an off-gas stream, and a catalytic reactor down stream of the PSA unit that converts carbon monoxide (CO) and hydrogen (H2) contained in the relatively pure hydrogen stream into methane (CH4) and water vapor (H2O). The method of purification involves generating a hydrogen-rich reformate gas at a temperature greater than 150 C in a fuel reforming reactor, separating the reformate gas into a relatively pure hydrogen stream and an off-gas stream in a pressure swing adsorption (PSA) hydrogen purification unit, and converting carbon monoxide (CO) and hydrogen (H2) contained in the relatively pure hydrogen stream into methane (CH4) and water vapor (H2O) in a catalytic reactor down stream of the PSA unit.Type: GrantFiled: September 28, 2006Date of Patent: October 21, 2008Assignee: Intelligent Energy, Inc.Inventors: Richard Root Woods, Brook Forest Porter, Kandaswamy Duraiswamy
-
Patent number: 7439274Abstract: A process (10) for producing liquid and, optionally, gaseous products from gaseous reactants includes feeding at a low level gaseous reactants (14) and, optionally, a portion of a recycle gas stream into a vertically extending slurry bed (70) of solid particles suspended in a suspension liquid inside a vessel (12), and feeding, as an additional gas feed (58), at least a portion of the recycle gas stream into the slurry bed (70) above the level at which the gaseous reactants (814) are fed into the slurry bed (70) and above the lower 20% of the vertical height of the slurry bed (70).Type: GrantFiled: May 12, 2004Date of Patent: October 21, 2008Assignee: SASOL Technology (Proprietary) LimitedInventors: André Peter Steynberg, Berthold Berend Breman
-
Patent number: 7439275Abstract: Anion-conducing polymers and membranes with enhanced stability to aqueous alkali include a polymer backbone with attached sulfonium, phosphazenium, phosphazene, and guanidinium residues. Compositions also with enhanced stability to aqueous alkali include a support embedded with sulfonium, phosphazenium, and guanidinium salts.Type: GrantFiled: March 22, 2006Date of Patent: October 21, 2008Assignee: Los Alamos National Security, LLCInventors: Bryan S. Pivovar, David L. Thorn
-
Patent number: 7439276Abstract: Aqueous-based, dispersed olefin polymers, froths, durable, open-cell foam compositions, structures and articles derived from same; methods for preparation of such froths and foams; and use of the dry durable foams in various applications are disclosed. Further described is use of the foams and structures and articles made of same in absorption, filtration, insulation, cushioning and backing applications, and in particular for odor removal, hygiene and medical applications due to, among other properties, good absorption capabilities, softness and/or flexibility of the foams and their recyclable nature.Type: GrantFiled: August 25, 2004Date of Patent: October 21, 2008Assignee: Dow Global Technologies Inc.Inventors: Gary M. Strandburg, Mark W. VanSumeren, Shaofu Wu, Luther E. Stockton, David R. Speth, Brad M. Moncla, Matthew J. Kalinowski
-
Patent number: 7439277Abstract: A process for the preparation of a hydroperoxide functionalized rubber compound by the conversion of triplet state oxygen to singlet state oxygen in the presence of oxygen and a light-induced photoreductant. A dispersion of an unsaturated rubber component in a carrier solvent is introduced into a reactor containing a permeable catalyst bed comprising a light-induced photoreductant component supported on a particulate substrate component and passed through the catalyst bed. A gaseous oxidizing agent is passed through the catalyst bed in contact with the rubber-containing dispersion. The catalyst bed is irradiated with electromagnetic light radiation in the ultraviolet or visible light range at an intensity sufficient to convert triplet oxygen in the oxygenated rubber component to singlet oxygen. The oxygenated rubber component is then recovered from the reactor.Type: GrantFiled: May 19, 2005Date of Patent: October 21, 2008Assignee: Fina Technology, Inc.Inventors: Jay Reimers, Jose Sosa
-
Patent number: 7439278Abstract: The invention concerns a photocurable adhesive composition comprising, based on total weight of photopolymerizable monomers and/or oligomers of the composition: (A1) 20 to 80 wt % of at least one diacrylate monomer or oligomer thereof (A1); (A2) 80 to 20 wt % of at least one dimethacrylate monomer or oligomer thereof; (B) 0 to 50 wt %, of at least one copolymerizable monomer different from components (A1) and (A2); with the proviso that the composition is free from any thio(meth)acrylate (—SCOCR??CH2, with R??H or CH3) monomer or oligomer thereof.Type: GrantFiled: May 4, 2004Date of Patent: October 21, 2008Assignee: Essilor International Compagnie Generale d'OptiqueInventor: Aref Jallouli
-
Patent number: 7439279Abstract: To provide a coating composition which forms a coating film having excellent fingerprint removability and having favorable abrasion resistance and transparency, and a molded product having a coating film made of a cured product of the composition. An active energy ray curable coating composition comprising an active energy ray curable polymerizable monomer (A), a water and oil repellency-imparting agent (B) and an active energy ray polymerization initiator (C), wherein the water and oil repellency-imparting agent (B) contains a water and oil repellency-imparting agent (B-T) having a moiety (b-1) exerting water and oil repellency, an active energy ray curable functional group (b-2) and a moiety (b-3) excellent in compatibility with the polymerizable monomer (A) and a molded product having a coating film made of a cured product of the composition.Type: GrantFiled: May 13, 2005Date of Patent: October 21, 2008Assignee: Asahi Glass Company, LimitedInventors: Satoshi Kondo, Daisuke Shirakawa, Toshihiko Higuchi, Hirotsugu Yamamoto
-
Patent number: 7439280Abstract: A lignocellulosic composite material and a method for preparing the lignocellulosic composite material are disclosed. The composite material is formed from lignocellulosic particles and a binder resin. The binder resin comprises a polyisocyanate, at least one of insecticide and/or fungicide that are dispersed throughout the polyisocyanate. The insecticide and/or fungicide is also dispersed throughout the lignocellulosic particles. Since the insecticide and/or fungicide is dispersed throughout the composite material, the composite material is insect resistant and is able to withstand insect attacks and prevent fungus growth and decay.Type: GrantFiled: April 6, 2004Date of Patent: October 21, 2008Assignee: BASF CorporationInventors: Limei Lu, Keith A. Holmes, Clark D. Klein, Donald C. Mente
-
Patent number: 7439281Abstract: There is provided a pigment dispersion comprising at least one resin-coated pigment comprising a resin and a pigment, and having an average particle diameter of 250 nm or less, and a dispersion medium containing as a major component a cation polymeric compound having a viscosity of 30 mPa.s or less at a temperature of 25° C. and a boiling point of 150° C. or more at 1 atm. The pigment is incorporated in the pigment dispersion at a ratio ranging from 3 to 41% by weight based on a total weight of the dispersion medium, and the resin is incorporated in the resin-coated pigment at a ratio ranging from 5 to 37% by weight based on the weight of the pigment.Type: GrantFiled: October 20, 2004Date of Patent: October 21, 2008Assignee: Toshiba Tec Kabushiki KaishaInventors: Toru Ushirogouchi, Ryozo Akiyama, Kazuhiko Ohtsu, Masashi Hiroki, Mitsuru Ishibashi
-
Patent number: 7439282Abstract: The present invention relates to a stimuli-responsive composition that comprises a polymer, a solvent and a substance having a predetermined function. One embodiment of the present invention is a composition comprising a block polymer, a solvent and a substance having a predetermined function. The present invention also relates to an ink composition containing the composition, an image-forming method and an image-forming apparatus using the composition, and a recording medium applying the composition. Further, the present invention relates to an ABC type block polymer compound wherein the polymer is an ABC type triblock polymer, and wherein at least one of the blocks in the triblock polymer changes in nature from solvophilic to solvophobic or from solvophobic to solvophilic in response to stimuli, and more preferably, the A component, then the B component, and finally the C component respond to the stimuli.Type: GrantFiled: May 6, 2005Date of Patent: October 21, 2008Assignee: Canon Kabushiki KaishaInventors: Koichi Sato, Ikuo Nakazawa, Sakae Suda, Masayuki Ikegami, Sadahito Aoshima, Shinji Sugihara
-
Patent number: 7439283Abstract: In order to provide a resin composition containing a lactic acid resin, and a molded article obtained from this resin composition which impart flame retardance to the resin composition and suppress a reduction in the molecular weight, use is made of a flame-retardant resin composition which contains a resin composition of which the major component is a lactic acid resin, and a surface-treated metallic hydroxide, wherein the surface-treated metallic hydroxide is added by 50-150 parts by mass per 100 parts by mass of the lactic acid resin.Type: GrantFiled: September 8, 2003Date of Patent: October 21, 2008Assignees: Mitsubishi Plastics, Inc., Sony CorporationInventors: Kazuya Tanaka, Jun Takagi, Shinichiro Yamada, Hiroyuki Mori, Yuko Fujihira
-
Patent number: 7439284Abstract: A method of making a thermoplastic composition comprises melt mixing a concentrate comprising a first thermoplastic, a second thermoplastic and an additive with a component selected from the group consisting of a third thermoplastic, fire retardant additive, reinforcing agent, electrically conductive filler, non-electrically conductive filler and combinations of two or more of the foregoing.Type: GrantFiled: March 31, 2004Date of Patent: October 21, 2008Assignee: Sabic Innovative Plastics IP B.V.Inventors: Montgomery M. Alger, Robert Hossan, Torben P. Kempers, Geoffrey H. Riding, David J. Swanson, Michael L. Todt
-
Patent number: 7439285Abstract: Liquid thermosetting ink for ink-jet applications includes at least a resin, at least one solid latent curing agent having a maximal particle size of less than 2 microns and an inert filler having fine particles. The single-pack or two-pack ink has a viscosity lower than 50 Cp at the application temperature, a surface tension lower than 80 dyn/cm at the application temperature, and a glass transition temperature of cured ink of greater than 120° C.Type: GrantFiled: January 23, 2004Date of Patent: October 21, 2008Assignee: Printar Ltd.Inventors: Jacob Mozel, Izhar Halahmi, Ran Vilk
-
Patent number: 7439286Abstract: A modified asphalt composition is provided comprising at least one plastomer, at least one elastomer, and asphalt. More specifically, a modified asphalt composition is provided comprising an oxidized polyethylene, a styrene-butadiene-styrene block copolymer, and asphalt. A hot mix asphalt composition is also provided comprising the modified asphalt composition and aggregate. Processes for producing the modified asphalt composition and the hot mix asphalt composition is also provided as well as articles produced from these inventive compositions.Type: GrantFiled: June 2, 2006Date of Patent: October 21, 2008Assignee: Westlake Longview CorporationInventors: Richard Kingsley Stuart, Jr., Jeffrey Lynn Presley, Louis Thomas Germinario
-
Patent number: 7439287Abstract: The present invention relates to a flame retardant thermoplastic resin composition that contains a phenol resin derivative having good char formability, regardless of the base resin. A flame retardant thermoplastic resin composition according to the present invention comprises (A) 100 parts by weight of a thermoplastic resin as a base resin, (B) about 0.1˜100 parts by weight of a phenol resin derivative, and (C) about 0.1˜50 parts by weight of a phosphorous compound or a mixture of phosphorous compounds.Type: GrantFiled: November 16, 2006Date of Patent: October 21, 2008Assignee: Cheil Industries Inc.Inventors: Jae Ho Yang, Sang Hyun Hong, Gyu Chul Lee, Young Gil Jang, Su Hak Bae